Meeder Asset Management Inc Intra Cellular Therapies, Inc. Transaction History

Meeder Asset Management Inc

  • $1.48 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$64.76 - $79.84 $2,396 - $2,954
-37 Reduced 44.05%
47 $3,000
Q1 2024

May 07, 2024
BUY
$64.37 - $75.65 $5,407 - $6,354
84 New
84 $5,000
Q2 2022

Aug 08, 2022
BUY
$43.0 - $65.64 $15,781 - $24,089
367 New
367 $21,000
Q3 2021

Nov 08, 2021
SELL
$28.72 - $42.49 $48,824 - $72,233
-1,700 Closed
0 $0
Q2 2021

Aug 09, 2021
BUY
$29.3 - $44.5 $49,810 - $75,650
1,700 New
1,700 $69,000
Q4 2020

Feb 09, 2021
SELL
$23.34 - $32.22 $36,923 - $50,972
-1,582 Closed
0 $0
Q3 2020

Nov 02, 2020
BUY
$17.61 - $31.86 $27,859 - $50,402
1,582 New
1,582 $41,000
Q2 2020

Aug 11, 2020
SELL
$14.35 - $26.64 $6,070 - $11,268
-423 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$12.31 - $33.12 $3,853 - $10,366
-313 Reduced 42.53%
423 $7,000
Q4 2019

Feb 13, 2020
SELL
$7.26 - $38.49 $2,969 - $15,742
-409 Reduced 35.72%
736 $26,000
Q3 2019

Oct 17, 2019
SELL
$7.47 - $14.03 $5,475 - $10,283
-733 Reduced 39.03%
1,145 $9,000
Q2 2019

Aug 05, 2019
BUY
$10.65 - $14.29 $16,677 - $22,378
1,566 Added 501.92%
1,878 $24,000
Q1 2019

Apr 16, 2019
SELL
$10.9 - $14.09 $4,654 - $6,016
-427 Reduced 57.78%
312 $4,000
Q4 2018

Jan 17, 2019
BUY
$10.36 - $20.96 $7,656 - $15,489
739 New
739 $8,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.1M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.72B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email